When you consider what they do in Japan already 350 000 prescriptions per year which still grows 40% Per year..
at Net Sale price of 520usd that is 180mln usd
we all know ( Euroz report ) or just ask Google for sales multiple for biipharm stock , 15x on average
will give you 2.7bln usd or 4.4bln aud or aud 3per share
that is without US population adjustment 2.5x
that is without growth 40% as per Japan
that is without re-fills - stickiness of US model ...3x??
Lets get FDA...yes 40c pre FDA is cheap..
This week we will be 100% de - risked and deserve to be over usd 1 per share....no more cents
When you consider what they do in Japan already 350 000...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $678.7M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.5¢ | 37.5¢ | $1.701M | 4.493M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 523247 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 146093 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |